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the degree of AR (Group B) while only one patient
showed progression of his AR after surgery. Those with
absent AR before surgery remained with no AR after sur-
gery. Improvement was found more in those with mild
degree of AR preoperatively compared to those with
moderate and severe AR. Female gender also showed
tendency to improve more as compared to male. Early
surgical closure is advisable for patients with VSD and
associated AV prolapse in order to achieve a better out-
come after repair and to prevent progression of AR in
future.
http://dx.doi:10.1016/j.jsha.2016.04.059
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Complete AVSD (CAVSD) is characterized by the pre-
sence of a common atrio-ventricular (AV) orifice, an
inter-atrial communication, and a ventricular septal
defect (VSD). Results of surgical correction of atrio-
ventricular septal defects (AVSDs) have improved over
the last decades; however, the need for reoperation for
left atrio-ventricular valve regurgitation, after primary
AVSD repair remains a major concern. The aim of our
study is to assess the outcome of the routine leaflet aug-
mentation technique in CAVSD repair. A retrospective
database and chart review analysis of all patients who
underwent AV canal repair at king Abdul-Aziz Cardiac
Center during period from 1999 to September 2014 was
conducted. Demographic data, associated anomalies,
operative data, ICU and hospital course were reviewed.
Early outcomes were reviewed for postoperative compli-
cations (Chylothorax, complete AV block, Arrhythmias,
early mortality) and late outcomes were reviewed for Left
AV valve regurgitation requiring for re-intervention and
late mortality. Two hundred and sixty patients under-
went leaflet augmentation technique to repair complete
AVSD, between January 1999 and September 2014. The
mean age was (131.5 months), and mean weight
(6.06 kg). A variety of concomitant procedures were per-
formed at the time of repair of the CAVSD, including a
total of 49 patients (18.8%) who underwent PDA ligation.
Repair of TV (Right AV valve) was performed in 11
patients (4.2%), 9 patients (3.46%) required RVOTO
resection, in 5 patients (1.92%), PA plasty was done and
2 patients (0.76%) required ECMO after CAVSD repair.
Regarding reoperations, a total of 17 patients (of 260)
required reoperation after initial CAVSD repair. The
most common indication for reoperation was left AV
valve regurgitation in 16 patients (6%) in the follow up
period up to 15 years. One patient (0.38%) required dia-
phragmatic plication. The overall mortality was 3 patients
(1.1%). Leaflet augmentation for the repair of the com-
plete AVSD, represent a good surgical alternative techni-
que, allows for good exposure, good LAVV
reconstruction and close to anatomical repair and results
in reduced incidence of late Left atrio-ventricular valve
regurgitation.
http://dx.doi:10.1016/j.jsha.2016.04.060
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Cardiac resynchronization therapy (CRT) has become
an increasingly important therapeutic option for patients
(pts) to treat dyssynchrony associated moderate and
severe heart failure. Few reports however, determined
the beneficial effects of CRT in pediatrics and midterm
outcome following this therapy. Our aim is to assess the
mid-term outcomes of CRT in children with evidence of
dyssynchrony associated heart failure. Cardiac resynchro-
nization therapy is beneficial in treating congenital heart
disease patientswho have evidence of dyssynchrony asso-
ciated heart failure. Retrospective review of 18 consecutive
pediatric patients who underwent CRT at our institution
between January 2002 andAugust 2011Cardiac resynchro-
nizationpacemakerwas implanted in 18pts themajority of
pts (14) with congenital heart disease. Fourteen pts had
preexisting complete heart block and chronic right ventri-
cular pacing. Epicardial left ventricular leads were
implanted in all pts while the atrial and right ventricular
leads approach varied according to the pt size and anat-
omy. Indication for CRT was symptomatic dilated cardio-
myopathy with evidence of electrical and/or mechanical
dyssynchrony demonstrated byM-mode, 3-D echo, or tis-
sue Doppler. The median age of this cohort was 14 years
(range 6 months–16 years), the median follow-up time
was 7.2 years (range 1–10 years). Subjectively, 16 out of
18 pts reported symptomatic improvementwith decreased
hospitalizations. The left ventricular ejection fraction
improved from mean of 27% (SD 13%) to mean of 50%
(SD 13%) (P value <0.001). Additionally, cardiomegaly
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improved significantly in during follow up (P value
<0.001). The QRS duration with CRT was less but the
change is not significant (P value = 0.1) suggesting that
electrical resynchronization is not a prerequisite for clini-
cal improvement in this cohort. Children including those
with congenital heart disease patients who have evidence
of dyssynchrony associated heart failure appear to benefit
from cardiac resynchronization therapy on the mid-term.
Selection criteria should include the use of new technolo-
gies to demonstrate mechanical dyssynchrony beside
other conventional indications of CRT. Further studies
looking at long-term benefits of CRT in pediatric and
CHD patients are needed.
http://dx.doi:10.1016/j.jsha.2016.04.061
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Heart failure is a major and growing public health pro-
blem; approximately 5 million patients in the USA have
heart failure. Depression is a serious mental illness that
interferes with daily life activities and quality of life of
Heart Failure Patients. Aim: To determine the association
between depression and the medication adherence in
patients with heart failure. Depression will reduce adher-
ence to medication in patients with heart failure Quality
project involving 50 patients with heart failure who have
regular visits in Cardiovascular Disease Management
Program in King Abdul-Aziz Cardiac Center. Two vali-
dated self-reporting tools; the Morisky Scale for Medica-
tion Adherence and the Patient Health Questionnaire
(PHQ) for assessment of depression will be used. Multi-
ple regression analysis with adjustment for covariates
will be used to examine the relationship between depres-
sion and medication adherence. 66% of patients were
male with mean age of 62 ±11 years, more than one third
(36%) had depression at different level, 61% of subjects in
this group showed low adherence rate compared to 6%
amongst those who had no depression (p < 0.001).
Depression has a major impact on the medication adher-
ence in patients with heart failure.
http://dx.doi:10.1016/j.jsha.2016.04.062
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PACING AND OTHER THERAPEUTIC DEVICES
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Background and objectives: Literature review revealed no
studies were done regarding the application of implanta-
ble defibrillator and cardiac resynchronization therapy
guidelines in Saudi Arabia. Therefore, our aim was to
identify the gap in the application of the guidelines for
acute on chronic systolic heart failure patients in Saudi
Arabia.
Design and setting: We used data from the heart func-
tion assessment registry trial in Saudi Arabia (HEARTS)
to explore the rate of device implantation. In consecutive
cohort admitted in 18 governmental hospitals with heart
failure between October 2009 and December 2010.
Results: Of 1664 patients with acute on chronic systolic
heart failure enrolled in the HEARTS registry, 227
(13.64%) have undergone a past ICD/CRT, 148 (8.9%)
patients with ICD and 79 (4.7%) patients with CRT. 1437
(86.36%) patients did not go through an ICD or a CRT.
From 71 VT/VF patients who are required to have an
ICD only 10 (14%) patients received an ICD therapy.
223 patients have a left bundle branch block and 35
(15.6%) of those patients received an ICD/CRT device.
From 831 patients with LVEF < 30%, 170 (20.5%) went
through a past ICD/CRT.
Conclusion: Since a large number of whom required an
ICD/CRT did not receive a device, a gap in the applica-
tion of ICD/CRT devices had been identified, further stu-
dies are required to establish the reason behind this.
http://dx.doi:10.1016/j.jsha.2016.04.063
Imaging
CATHETER-BASED CORONARY IMAGING AND
HEMODYNAMICS
63. Clinical and angiographic profile of myocardial
bridges in patients undergoing coronary angiogram
for evaluation of chest pain
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A myocardial bridge is a band of heart muscle that lies
on top of a coronary artery, instead of underneath it. First
described by pathologists in the early l920’s, myocardial
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